Cleveland Clinic London and Bupa UK Insurance have expanded their healthcare partnership into cardiac care, introducing an outcome-based programme that links reimbursement to measurable improvements in patient health. The initiative…
Abbott has entered a multi-year collaboration with Google Health to bring continuous glucose insights into a broader digital health experience, combining data from Abbott's Lingo biowearable with Google's consumer health…
A research team led by the University of Dubai has developed an artificial intelligence-powered screening tool that could help identify children at higher risk of autism spectrum disorder at an…
The Philippines has secured a $600 million grant from the United States to expand healthcare access, strengthen the country's health system and improve its ability to respond to future public…
A new analysis commissioned by Prostate Cancer Research suggests that a targeted prostate cancer screening programme for men at higher risk could be introduced across the UK without placing an…
Temple University and U.K.-based digital health company Aide Health have joined forces to develop a technology-enabled approach aimed at improving how patients with type 2 diabetes receive ongoing support outside…
Imricor Medical Systems has broadened its interventional magnetic resonance imaging (iMRI) portfolio with the introduction of Imricor Cardiovascular, a dedicated business focused on advancing radiation-free cardiac catheterization. The launch marks…
Livlong365 has expanded its digital healthcare ecosystem with the launch of SurgiCare, a comprehensive surgery care coordination service designed to simplify the treatment journey for patients undergoing planned surgical procedures.…
Saint Lucia has taken a significant step toward improving its national cancer control strategy with the official launch of its National Cancer Registry, a centralized platform designed to collect, analyze,…
Summit Therapeutics has expanded its oncology development strategy with the launch of HARMONi-GU1, a global Phase II/III clinical trial evaluating ivonescimab in combination with an antibody-drug conjugate for the treatment…